Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CMS: No Idea When We’ll Meet Sunshine Deadline
Pharmalot
Tuesday, November 1, 2011 - 12:23pm
tags:
Physician Payment Sunshine Act, CMS, physicial payments
Eisai First-Half Profit Falls 17% as Aricept Sales Decline
Bloomberg
Tuesday, November 1, 2011 - 12:22pm
tags:
Eisai, earnings
NPS Pharmaceuticals' Selloff Was Overdone
Seeking Alpha
Tuesday, November 1, 2011 - 12:21pm
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Watson Pharma Hikes Outlook; Court Decision Weighs
Investors.com
Tuesday, November 1, 2011 - 12:19pm
tags:
Watson, earnings
4 Pharma Stocks Poised To Get FDA Approval
Seeking Alpha
Tuesday, November 1, 2011 - 11:13am
tags:
JNJ, Eli Lilly, Pfizer
5 One-Drug Wonders Going for No. 2
Motley Fool
Tuesday, November 1, 2011 - 11:09am
tags:
Dendreon, Provenge, DN24-02, Elan, Tysabri, bapineuzumab, ONYX Pharmaceuticals, Bayer, regorafenib, Carfilzomib, Nexavar, Vertex, Merck, Incivek, Kalydeco, Momenta, Lovenox, Copaxone, Teva Pharmaceuticals
Vical: All Systems Are Go
Seeking Alpha
Tuesday, November 1, 2011 - 11:06am
tags:
Vical, earnings
Exelixis clashes with FDA over prostate cancer study, shares tank
Fierce Biotech
Tuesday, November 1, 2011 - 11:05am
tags:
prostate cancer, FDA, Exelixis, cabozantinib
Hyperactivity Drugs Shown Not to Raise Heart Risks in Children
Bloomberg
Tuesday, November 1, 2011 - 11:03am
tags:
ADHD, Shire, Adderall, Novartis, Ritalin, Concerta, JNJ
YM BioSciences' Upcoming CYT387 Catalyst May Be One To Watch
Seeking Alpha
Tuesday, November 1, 2011 - 11:02am
tags:
CYT387, YM BioSciences
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tuesday, November 1, 2011 - 9:01am
tags:
Pharmasset, hepatitis C, Ribavirin, Vertex, Abbott Laboratories, PSI-7977, JNJ, Roche, Bristol-Myers Squibb
Pfizer 3rd-quarter net jumps; '11 outlook lifted
Markewatch
Tuesday, November 1, 2011 - 8:59am
tags:
Pfizer, earnings
Neurocrine Biosciences 3Q profit, revenue surge
Yahoo/AP
Tuesday, November 1, 2011 - 8:58am
tags:
Neurocrine, earnings
GSK: It’s Worth Paying Up for this Pipeline, Says Analyst
Barron's
Tuesday, November 1, 2011 - 8:56am
tags:
GSK
Merck's Penance Has Gone On Long Enough
Investopedia
Tuesday, November 1, 2011 - 8:55am
tags:
Merck, Alexion, Forest Labs, JNJ, Gilead, Eli Lilly, Novartis, Pfizer, Vertex
Can Biotechnology Help Curb The Deficit Crisis?
Patent Baristas
Monday, October 31, 2011 - 12:41pm
tags:
deficit, biotech, innovation, R&D
Daiichi Sankyo Cuts Full-Year Sales Forecast on Stronger Yen
Bloomberg
Monday, October 31, 2011 - 12:00pm
tags:
earnings, Daiichi Sankyo
NPS Pharmaceuticals Shares Plunge on Bowel Drug Study Deaths
Bloomberg
Monday, October 31, 2011 - 11:53am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Momenta climbs on delay for competing drug
Yahoo/AP
Monday, October 31, 2011 - 11:52am
tags:
Momenta, bloodthinner, enoxaparin, Lovenox, Sandoz, Amphastar
Seattle Genetics Inc. Third Quarter Earnings on Horizon
Yahoo/Wall St. Cheat Sheet
Monday, October 31, 2011 - 11:51am
tags:
earnings, Seattle Genetics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.